Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd., trading on Nasdaq under the ticker AFJK, is a blank check company focused on the health technology sector. The company filed a 10-Q with the Securities and Exchange Commission on May 13, 2024, under accession number 0001493152-24-018883, reflecting its status as a reporting public entity during its search for a business combination target. AFJK targets opportunities in the healthcare and health technology industry, consistent with its stated acquisition mandate. The SPAC completed its initial public offering in 2023. For full filing history, deal status, shareholder data, and real-time alerts on AFJK and hundreds of other active SPACs, sign up for a SpacDesk account at spacdesk.com.